GC
Firstly i think its a good idea to get a list of questions before hand so hopefully all our queries will be answered on the day so Ross can get a feel of what the share holders want answered so keep them coming. I would like less time on reciting the newsletter as im sure that everyone thats bothers to call up has no doubt read the the letter numerous times and more time allocated to questions.
My main questions would be a continuation of HT in regards to a successful oxyC results. I would like a frank response of:
Are we talking to pharma about a deal?
If we are, what is there response?
What is chance of doing deal after next results?
If no deal, what else do we need to do?
How long would further testing take?
How expensive will further testing be and how do we pay for it as well as completing trials for oxyM.
All this may be covered in the newsletter but i just think at 1.5c management can at least show us the decency on where exactly we are with our hopefully successful oxy C results
- Forums
- ASX - By Stock
- AVE
- Newsletter
AVE
avecho biotechnology limited
Add to My Watchlist
0.00%
!
0.4¢

Newsletter, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.10M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 34619260 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 8218985 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 34619260 | 0.003 |
15 | 16879866 | 0.002 |
15 | 57221222 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 8218985 | 6 |
0.005 | 13262502 | 18 |
0.006 | 31623747 | 5 |
0.007 | 4498187 | 12 |
0.008 | 4722624 | 6 |
Last trade - 07.32am 07/07/2025 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online